Does ARIPIPRAZOLE Cause Product dose omission issue? 578 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 578 reports of Product dose omission issue have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.9% of all adverse event reports for ARIPIPRAZOLE.
578
Reports of Product dose omission issue with ARIPIPRAZOLE
0.9%
of all ARIPIPRAZOLE reports
21
Deaths
108
Hospitalizations
How Dangerous Is Product dose omission issue From ARIPIPRAZOLE?
Of the 578 reports, 21 (3.6%) resulted in death, 108 (18.7%) required hospitalization, and 3 (0.5%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 578 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ARIPIPRAZOLE Alternatives Have Lower Product dose omission issue Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE